Drug-induced Angle-Closure Glaucoma
- PMID: 27990064
- PMCID: PMC5159452
- DOI: 10.5005/jp-journals-10008-1100
Drug-induced Angle-Closure Glaucoma
Abstract
Drug-induced angle-closure glaucoma is an important entity for the ophthalmologist as well as the general physician as it represents a preventable cause of potential blindness. This brief review highlights the fact that a high index of suspicion, in a susceptible individual followed by confirmation on appropriate imaging modality (UBM, ultrasound or anterior segment OCT) can alleviate the threat to sight and also help to institute appropriate therapy.
Keywords: Acute angle closure; Drug-induced glaucoma..
Conflict of interest statement
Source of support: Nil Conflict of interest: None declared
References
-
- Razeghinejad MR, Myers JS, Katz LJ. Iatrogenic glaucoma secondary to medications. Am J Med. 2011 Jan;124(1):20–25. - PubMed
-
- Berdy GJ, Berdy SS, Odin LS, Hirst LW. Angle closure glaucoma precipitated by aerosolized atropine. Arch Intern Med. 1991 Aug;151:1658–1660. - PubMed
-
- Lachkar Y, Bouassida W. Drug-induced acute angle closure glaucoma. Curr Opin Ophthalmol. 2007 Mar;18(2):129–133. - PubMed
-
- Lachkar Y, Migdal C, Dhanjil S. Effect of brimonidine tartrate on ocular hemodynamic measurements. Arch Ophthalmol. 1998 Dec;116(12):1591–1594. - PubMed
Publication types
LinkOut - more resources
Full Text Sources